# Nuclide record jeremie-calais (person). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/people/jeremie-calais/>
  a schema:Person ;
  nuclide:kind "person" ;
  schema:identifier "jeremie-calais" ;
  schema:name "Jeremie Calais"@en ;
  schema:description "Runs the UCLA theranostics trials that test PSMA imaging against conventional scans and lutetium against chemotherapy."@en ;
  schema:url <https://nuclide.cc/people/jeremie-calais/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.uclahealth.org/providers?q=Jeremie%20Calais>, <https://pubmed.ncbi.nlm.nih.gov/?term=Calais%20J%5BAuthor%5D>, <https://scholar.google.com/scholar?q=Jeremie%20Calais> ;
  schema:jobTitle "Associate Professor; Director, Clinical Research Program, Ahmanson Translational Theranostics Division, UCLA" ;
  nuclide:related <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:technologies <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/technologies/radioligand-therapy/> ;
  nuclide:targets <https://nuclide.cc/targets/psma/> ;
  nuclide:institutions <https://nuclide.cc/institutions/ucla-jonsson/> ;
  nuclide:journals <https://nuclide.cc/journals/journal-of-nuclear-medicine/> ;
  schema:affiliation <https://nuclide.cc/institutions/ucla-jonsson/> .
